AMPHADASE (Amphastar Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the AMPHADASE drug offered from Amphastar Pharmaceuticals, Inc.. This Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amphastar Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | hyaluronidase |
| SUBSTANCE NAME: | HYALURONIDASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-10-26 |
| END MARKETING DATE: | 0000-00-00 |
AMPHADASE HUMAN PRESCRIPTION DRUG Details:
| Item Description | AMPHADASE from Amphastar Pharmaceuticals, Inc. |
| LABELER NAME: | Amphastar Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150([USP’U]/mL) |
| START MARKETING DATE: | 2004-10-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0548-9090_9d798dca-17f4-4ab4-9c1e-7d6f4f1bfa40 |
| PRODUCT NDC: | 0548-9090 |
| APPLICATION NUMBER: | NDA021665 |
Other HYALURONIDASE Pharmaceutical Manufacturers / Labelers:
